-
1
-
-
0036764008
-
Características e indicaciones del levetirazetam.
-
Herranz JL, Argumosa A. Características e indicaciones del levetirazetam. Rev Neurol 2002;35(Suppl. 1):110-6.
-
(2002)
Rev Neurol
, vol.35
, Issue.SUPPL. 1
, pp. 110-116
-
-
Herranz, J.L.1
Argumosa, A.2
-
2
-
-
0032563178
-
Evidence for a unique profile of levetiracem in rodent models of seizures and epilepsy
-
Klitgaard H, Matagne A, Gobert J, Wülfert E. Evidence for a unique profile of levetiracem in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191-206.
-
(1998)
Eur J Pharmacol
, vol.353
, pp. 191-206
-
-
Klitgaard, H.1
Matagne, A.2
Gobert, J.3
Wülfert, E.4
-
3
-
-
0034864144
-
Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?
-
Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 2001;42(Suppl. 4):13-8.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 4
, pp. 13-18
-
-
Klitgaard, H.1
-
4
-
-
0033854805
-
Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
-
Cereguino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000;55:236-42.
-
(2000)
Neurology
, vol.55
, pp. 236-242
-
-
Cereguino, J.J.1
Biton, V.2
Abou-Khalil, B.3
Dreifuss, F.4
Gauer, L.J.5
Leppik, I.6
-
5
-
-
0033811027
-
Multicenter double-blind, randomized, placebo-controlled trial of levetirazetam as add-on therapy in patients with refractory partial seizures
-
Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetirazetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179-86.
-
(2000)
Epilepsia
, vol.41
, pp. 1179-1186
-
-
Shorvon, S.D.1
Lowenthal, A.2
Janz, D.3
Bielen, E.4
Loiseau, P.5
-
6
-
-
0033775210
-
Efficacy and tolerability of levetiracetam 3,000 mg/day in patients with refractory partial onset seizures: A multicenter double-blind, responder-selected study evaluating monotherapy
-
Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3,000 mg/day in patients with refractory partial onset seizures: a multicenter double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276-83.
-
(2000)
Epilepsia
, vol.41
, pp. 1276-1283
-
-
Ben-Menachem, E.1
Falter, U.2
-
7
-
-
0034162331
-
A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam 2,000 mg daily and 4,000 mg daily, without titration in patients with refractory epilepsy
-
Betts T, Waegemans T, Crawford P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam 2,000 mg daily and 4,000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9:80-7.
-
(2000)
Seizure
, vol.9
, pp. 80-87
-
-
Betts, T.1
Waegemans, T.2
Crawford, P.3
-
8
-
-
33645562210
-
Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: Report of two cases
-
Della Marca G, Vollono C, Mariotti P, Mazza M, Mennuni GF, Tonali P, et al. Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: report of two cases. J Neurol Neurosurg Psychiatry 2006;566-7.
-
(2006)
J Neurol Neurosurg Psychiatry
, pp. 566-567
-
-
Della Marca, G.1
Vollono, C.2
Mariotti, P.3
Mazza, M.4
Mennuni, G.F.5
Tonali, P.6
|